Human Vaccines & Immunotherapeutics (Aug 2021)

Letter to the editor concerning the article ‘Safety of vaccines administration in hereditary fructose intolerance’

  • Rebeca Saborido-Fiaño,
  • Nazareth Martinón-Torres,
  • Vanesa Crujeiras-Martinez,
  • Maria Luz Couce,
  • Rosaura Leis

DOI
https://doi.org/10.1080/21645515.2021.1891816
Journal volume & issue
Vol. 17, no. 8
pp. 2593 – 2594

Abstract

Read online

The most important approach for the management of hereditary fructose intolerance is a strict avoidance of fructose, sucrose and sorbitol from the diet and medications. A safe threshold of 2.4 mg/kg/dose was recently established by the Instituto Superiore di Sanità of Italy for both oral and parenteral routes, thus shouldering a safe administration of a majority of vaccines in these patients. This would not include, Rotarix® pre-established oral suspension and Rotateq® vaccines, which are indeed contraindicated. Moreover, Rotarix® white powder and solvent for oral suspension would only be safely administered at a weight above 9.3 kg. Overall, these recommendations to avoid rotavirus vaccination are difficult to implement because these vaccines are given during exclusive breastfeeding, prior to fructose-containing food introduction.

Keywords